Open Access
Issue
Parasite
Volume 31, 2024
Article Number 66
Number of page(s) 16
DOI https://doi.org/10.1051/parasite/2024049
Published online 29 October 2024
  1. Abou-El-Naga IF. 2018. Towards elimination of schistosomiasis after 5000 years of endemicity in Egypt. Acta Tropica, 181, 112–121. [CrossRef] [PubMed] [Google Scholar]
  2. Adenowo AF, Oyinloye BE, Ogunyinka BI, Kappo AP. 2015. Impact of human schistosomiasis in sub-Saharan Africa. Brazilian Journal of Infectious Diseases, 19(2), 196–205. [CrossRef] [Google Scholar]
  3. Adoubryn KD, Ouhon J, Yapo CG, Assoumou EY, Ago KML, Assoumou A. 2006. Epidemiological profile of the schistosomiasis in school children in the Agneby Region (south-east of Côte-d’Ivoire). Bulletin de la Société de Pathologie Exotique, 99(1), 28–31. [CrossRef] [PubMed] [Google Scholar]
  4. Adoubryn KD, Kouadio-Yapo CG, Ouhon J, Aka N, Bintto F, Assoumou A. 2012. Parasitoses intestinales infantiles à Biankouma, région des 18 Montagnes (ouest de la Côte d’Ivoire): étude de l’efficacité et de la tolérance du praziquantel et de l’albendazole. Médecine et Santé Tropicales, 22(2), 170–176. [CrossRef] [PubMed] [Google Scholar]
  5. Amuta E, Houmsou R. 2014. Prevalence, intensity of infection and risk factors of urinary schistosomiasis in pre-school and school aged children in Guma Local Government Area, Nigeria. Asian Pacific Journal of Tropical Medicine, 7(1), 34–39. [CrossRef] [PubMed] [Google Scholar]
  6. Angora EK, Boissier J, Menan H, Rey O, Tuo K, Touré OA, Coulibaly JT, Méité A, Raso G, N’Goran EK, Jürg Utzinger J, Oliver Balmer O. 2019. Prevalence and risk factors for schistosomiasis among schoolchildren in two settings of Côte d’Ivoire. Tropical Medicine and Infectious Disease, 4(3), 110. [CrossRef] [Google Scholar]
  7. Assaré RK, Lai YS, Yapi A, Tian-Bi YNT, Ouattara M, Yao PK, Knopp S, Vounatsou P, Utzinger J, N’Goran EK. 2015. The spatial distribution of Schistosoma mansoni infection in four regions of western Côte d’Ivoire. Geospatial Health, 10(1), 345. [PubMed] [Google Scholar]
  8. Assaré RK, N’Tamon RN, Bellai LG, Koffi JA, Mathieu TBI, Ouattara M, Eveline Hürlimann E, Coulibaly JT, Diabaté S, N’Goran EK, Utzinger J. 2020. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d’Ivoire. Parasites & Vectors, 13, 337. [CrossRef] [PubMed] [Google Scholar]
  9. Assaré RK, Tian-Bi YNT, Yao PK, N’Guessan NA, Ouattara M, Yapi A, Coulibaly JT, Meïté A, Hürlimann E, Stefanie Knopp S, Utzinger J, N’Goran EK. 2016. Sustaining control of schistosomiasis mansoni in Western Côte d’Ivoire: results from a SCORE Study, one year after initial praziquantel administration. PLoS Neglected Tropical Diseases, 10(1), e0004329. [CrossRef] [PubMed] [Google Scholar]
  10. Assaré RK, Tra MBI, Ouattara M, Hürlimann E, Coulibaly JT, N’Goran EK, Utzinger J. 2018. Sensitivity of the point-of-care circulating cathodic antigen urine cassette test for diagnosis of Schistosoma mansoni in low-endemicity settings in Côte d’Ivoire. American Journal of Tropical Medicine and Hygiene, 99(6), 1567–1572. [CrossRef] [PubMed] [Google Scholar]
  11. Bärenbold O, Garba A, Colley DG, Fleming FM, Haggag AA, Ramzy RMR, Assaré RK, Tukahebwa EM, Mbonigaba JB, Bucumi V, Kebede B, Yibi MS, Meité A, Coulibaly JT, N’Goran EK, Tchuem Tchuenté LA, Mwinzi P, Utzinger J, Vounatsou P. 2018. Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test. PLoS Neglected Tropical Diseases, 12(12), e0006941. [CrossRef] [PubMed] [Google Scholar]
  12. Bezerra DF, Pinheiro MCC, Barbosa L, Viana AG, Fujiwara RT, Bezerra FSM. 2021. Diagnostic comparison of stool exam and point-of-care circulating cathodic antigen (POC-CCA) test for Schistosomiasis mansoni diagnosis in a high endemicity area in northeastern Brazil. Parasitology, 148(4), 420–426. [CrossRef] [PubMed] [Google Scholar]
  13. Bezerra FSM, Leal JKF, Sousa MS, Pinheiro MCC, Ramos AN Jr, Silva-Moraes V, Katz N. 2018. Evaluating a point-of-care circulating cathodic antigen test (POC-CCA) to detect Schistosoma mansoni infections in a low endemic area in north-eastern Brazil. Acta Tropica, 182, 264–270. [CrossRef] [PubMed] [Google Scholar]
  14. Bergquist R, Johansen MV, Utzinger J. 2009. Diagnostic dilemmas in helminthology: what tools to use and when? Trends in Parasitology, 25(4), 151–156. [CrossRef] [PubMed] [Google Scholar]
  15. Calasans TAS, Souza GTR, Melo CM, Madi RR, Jeraldo VDLS. 2018. Socioenvironmental factors associated with Schistosoma mansoni infection and intermediate hosts in an urban area of northeastern Brazil. PLoS One, 13(5), e0195519. [CrossRef] [PubMed] [Google Scholar]
  16. Casacuberta-Partal M, Hoekstra PT, Kornelis D, van Lieshout L, van Dam GJ. 2019. An innovative and user-friendly scoring system for standardised quantitative interpretation of the urine-based point-of-care strip test (POC-CCA) for the diagnosis of intestinal schistosomiasis: a proof-of-concept study. Acta Tropica, 199, 105150. [CrossRef] [PubMed] [Google Scholar]
  17. Clements MN, Corstjens PLAM, Binder S, Campbell CH Jr, de Dood CJ, Fenwick A, Harrison W, Kayugi D, King CH, Kornelis D, Ndayishimiye O, Ortu G, Lamine MS, Zivieri A, Colley DG, van Dam GJ. 2018. Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi. Parasites & Vectors, 11(1), 111. [CrossRef] [PubMed] [Google Scholar]
  18. Coelho PRS, Ker FTO, Araújo AD, RicardoJPS Guimarães, Negrão-Corrêa DA, Caldeira RL, Geiger SM. 2021. Identification of risk areas for intestinal schistosomiasis, based on malacological and environmental data and on reported human cases. Frontiers in Medicine, 8, 642348. [CrossRef] [PubMed] [Google Scholar]
  19. Colley DG, Andros TS, Campbell CH. 2017. Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs? Infectious Diseases of Poverty, 6(1), 63. [CrossRef] [PubMed] [Google Scholar]
  20. Colley DG, Bustinduy AL, Secor WE, King CH. 2014. Human schistosomiasis. Lancet, 383(9936), 2253–2264. [CrossRef] [PubMed] [Google Scholar]
  21. Colley DG, King CH, Kittur N, Ramzy RMR, Secor WE, Fredericks-James M, Ortu G, Clements MN, Ruberanziza E, Umulisa I, Wittmann U, Campbell CH. 2020. Evaluation, validation, and recognition of the point-of-care circulating cathodic antigen, urine-based assay for mapping Schistosoma mansoni infections. American Journal of Tropical Medicine and Hygiene, 103(1_Suppl), 42–49. [CrossRef] [PubMed] [Google Scholar]
  22. Colley DG, Ramzy RMR, Maganga J, Kinung’hi S, Odiere MR, Musuva RM, Campbell CH Jr. 2023. The POC-CCA assay for detection of schistosoma mansoni infection needs standardization in production and proper quality control to be reliable. Acta Tropica, 238, 106795. [CrossRef] [PubMed] [Google Scholar]
  23. Davis A. 2004. Clinical trials in parasitic diseases. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98(3), 139–141. [CrossRef] [PubMed] [Google Scholar]
  24. Elmorshedy H, Bergquist R, Fayed A, Guirguis W, Abdel-Gawwad E, Eissa S, Barakat R. 2020. Elimination of schistosomiasis requires multifactorial diagnostics: evidence from high- and low-prevalence areas in the Nile Delta, Egypt. Infectious Diseases of Poverty, 9(1), 31. [CrossRef] [PubMed] [Google Scholar]
  25. Enk MJ, Lima AC, Drummond SC, Schall VT, Coelho PM. 2008. The effect of the number of stool samples on the observed prevalence and the infection intensity with Schistosoma mansoni among a population in an area of low transmission. Acta Tropica, 108(2–3), 222–228. [CrossRef] [PubMed] [Google Scholar]
  26. Ferreira FT, Fidelis TA, Pereira TA, Otoni A, Queiroz LC, Amâncio FF, Antunes CM, Lambertucci JR. 2017. Sensitivity and specificity of the circulating cathodic antigen rapid urine test in the diagnosis of Schistosomiasis mansoni infection and evaluation of morbidity in a low- endemic area in Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 50(3), 358–364. [CrossRef] [PubMed] [Google Scholar]
  27. Fuss A, Mazigo HD, Tappe D, Kasang C, Mueller A. 2018. Comparison of sensitivity and specificity of three diagnostic tests to detect Schistosoma mansoni infections in school children in Mwanza region, Tanzania. PLoS One, 13(8), e0202499. [CrossRef] [PubMed] [Google Scholar]
  28. Gazzinelli A, Velasquez-Melendez G, Crawford SB, LoVerde PT, Correa-Oliveira R, Kloos H. 2006. Socioeconomic determinants of schistosomiasis in a poor rural area in Brazil. Acta Tropica, 99(2–3), 260–271. [CrossRef] [PubMed] [Google Scholar]
  29. Grenfell R, Harn DA, Tundup S, Da’dara A, Siqueira L, Coelho PMZ. 2013. New approaches with different types of circulating cathodic antigen for the diagnosis of patients with low Schistosoma mansoni load. PLoS Neglected Tropical Diseases, 7(2), e2054. [CrossRef] [PubMed] [Google Scholar]
  30. Hailu T, Mulu W, Abera B. 2020. Effects of water source, sanitation and hygiene on the prevalence of Schistosoma mansoni among school age children in Jawe District, Northwest Ethiopia. Iranian Journal of Parasitology, 15(1), 124–129. [PubMed] [Google Scholar]
  31. Hajissa K, Muhajir AEMA, Eshag HA, Alfadel A, Nahied E, Dahab R, Ali SM, Mohammed M, Gaafar M, Mohamed Z. 2018. Prevalence of schistosomiasis and associated risk factors among school children in Um-Asher Area, Khartoum, Sudan. BMC Research Notes, 11, 779. [CrossRef] [PubMed] [Google Scholar]
  32. Hinz R, Schwarz NG, Hahn A, Frickmann H. 2017. Serological approaches for the diagnosis of schistosomiasis – a review. Molecular and Cellular Probes, 31, 2–21. [CrossRef] [PubMed] [Google Scholar]
  33. Hoekstra PT, Casacuberta-Partal M, van Lieshout L, Corstjens PLAM, Tsonaka R, Assaré RK, Silué KD, Meité A, N’Goran EK, N’Gbesso YK, Amoah AS, Roestenberg M, Knopp S, Utzinger J, Coulibaly JT, van Dam GJ. 2020. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d’Ivoire based on Kato-Katz and POC-CCA: an open-label, randomised controlled trial (RePST. PLoS Neglected Tropical Diseases, 14(3), e0008189. [CrossRef] [PubMed] [Google Scholar]
  34. Ismail HAHA, Hong ST, Babiker ATEB, Hassan RMAE, Sulaiman MAZ, Jeong HG, Kong WH, Lee SH, Cho HI, Nam HS, Oh CH, Lee YH. 2014. Prevalence, risk factors, and clinical manifestations of schistosomiasis among school children in the White Nile River basin, Sudan. Parasites & Vectors, 7, 478. [CrossRef] [PubMed] [Google Scholar]
  35. Joof E, Sanyang AM, Camara Y, Sey AP, Baldeh I, Jah SL, Ceesay SJ, Sambou SM, Sanyang S, Wade CM, Sanneh B. 2021. Prevalence and risk factors of schistosomiasis among primary school children in four selected regions of The Gambia. PLoS Neglected Tropical Diseases, 15(5), e0009380. [CrossRef] [PubMed] [Google Scholar]
  36. Jones IJ, Sokolow SH, Chamberlin AJ, Lund AJ, Jouanard N, Bandagny L, Ndione R, Senghor S, Schacht AM, Riveau G, Hopkins SR, Rohr JR, Remais JV, Lafferty KD, Kuris AM, Wood CL, De Leo G. 2021. Schistosome infection in Senegal is associated with different spatial extents of risk and ecological drivers for Schistosoma haematobium and S. mansoni. PLoS Neglected Tropical Diseases, 15(9), e0009712. [CrossRef] [PubMed] [Google Scholar]
  37. Kalinda C, Chimbari M, Mukaratirwa S. 2017. Implications of changing temperatures on the growth, fecundity and survival of intermediate host snails of schistosomiasis: a systematic review. International Journal of Environmental Research and Public Health, 14(1), 80. [CrossRef] [PubMed] [Google Scholar]
  38. Katz N, Chaves A, Pellegrino J. 1972. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Revista do Instituto de Medicina Tropical de São Paulo, 14(6), 397–400. [Google Scholar]
  39. King CH. 2010. Parasites and poverty: the case of schistosomiasis. Acta Tropica, 113(2), 95–104. [CrossRef] [PubMed] [Google Scholar]
  40. Kongs A, Marks G, Verlé P, Van der Stuyft P. 2001. The unreliability of the Kato-Katz technique limits its usefulness for evaluating S. mansoni infections. Tropical Medicine & International Health, 6(3), 163–169. [CrossRef] [PubMed] [Google Scholar]
  41. Lamberti O, Kabatereine NB, Tukahebwa EM, Chami GF. 2021. Schistosoma mansoni infection risk for school-aged children clusters within households and is modified by distance to freshwater bodies. PLoS One, 16(11), e0258915. [CrossRef] [PubMed] [Google Scholar]
  42. Lambertucci JR, Drummond SC, Voieta I, de Queiróz LC, Pereira PP, Chaves BA, Botelho PP, Prata PH, Otoni A, Vilela JF, Antunes CM. 2013. An outbreak of acute Schistosoma mansoni schistosomiasis in a nonendemic area of Brazil: a report on 50 cases, including 5 with severe clinical manifestations. Clinical Infectious Diseases, 57(1), e1–e6. [CrossRef] [PubMed] [Google Scholar]
  43. Li YS, Raso G, Zhao ZY, He YK, Ellis MK, McManus DP. 2007. Large water management projects and schistosomiasis control, Dongting Lake Region, China. Emerging Infectious Diseases, 13(7), 973–979. [CrossRef] [PubMed] [Google Scholar]
  44. Lodh N, Mwansa JC, Mutengo MM, Shiff CJ. 2013. Diagnosis of Schistosoma mansoni without the stool: comparison of three diagnostic tests to detect Schistosoma [corrected] mansoni infection from filtered urine in Zambia. American Journal of Tropical Medicine and Hygiene, 89(1), 46–50. [CrossRef] [PubMed] [Google Scholar]
  45. Mawa PA, Kincaid-Smith J, Tukahebwa EM, Webster JP, Wilson S. 2021. Schistosomiasis morbidity hotspots: roles of the human host, the parasite and their interface in the development of severe morbidity. Frontiers in Immunology, 12, 635869. [CrossRef] [PubMed] [Google Scholar]
  46. M’Bra RK, Kone B, Yapi YG, Silué KD, Sy I, Vienneau D, Soro N, Cissé G, Utzinger J. 2018. Risk factors for schistosomiasis in an urban area in northern Côte d’Ivoire. Infectious Diseases of Poverty, 7(1), 47. [CrossRef] [PubMed] [Google Scholar]
  47. Menjetta T, Debalke S, Dana D. 2019. Schistosoma mansoni infection and risk factors among the fishermen of Lake Hawassa, southern Ethiopia. Journal of Biosocial Science, 51(6), 817–826. [CrossRef] [PubMed] [Google Scholar]
  48. Mewamba EM, Tiofack AAZ, Kamdem CN, Ngassam RIK, Mbagnia MCT, Nyangiri O, Noyes H, Womeni HM, Njiokou F, Simo G. 2021. Field assessment in Cameroon of a reader of POC-CCA lateral flow strips for the quantification of Schistosoma mansoni circulating cathodic antigen in urine. PLoS Neglected Tropical Diseases, 15(7), e0009569. [CrossRef] [PubMed] [Google Scholar]
  49. Mewamba EM, Tiofack AAZ, Kamdem CN, Tchounkeu EY, Tatang RJA, Mengoue LET, Mbagnia MCT, Njiokou F, Casacuberta-Partal M, Womeni HM, Simo G, TrypanoGEN+ Research Group of the H3Africa Consortium. 2022. Fine-scale mapping of Schistosoma mansoni infections and infection intensities in sub-districts of Makenene in the Centre region of Cameroon. PLoS Neglected Tropical Diseases, 16(10), e0010852. [CrossRef] [PubMed] [Google Scholar]
  50. Mnkugwe RH, Minzi OS, Kinung’hi SM, Kamuhabwa AA, Aklillu E. 2020. Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania. PLoS One, 15(2), e0228770. [CrossRef] [PubMed] [Google Scholar]
  51. Mueller A, Fuss A, Ziegler U, Kaatano GM, Mazigo HD. 2019. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors. BMC Infectious Diseases, 19(1), 832. [CrossRef] [PubMed] [Google Scholar]
  52. Ndamukong KJ, Ayuk MA, Dinga JS, Akenji TN, Ndiforchu VA, Titanji VP. 2000. The pattern of soil-transmitted nematode infections in primary school children of the Kumba Health District, South-West Cameroon. African Journal of Health Sciences, 7(3–4), 103–106. [PubMed] [Google Scholar]
  53. N’gbesso NJ-P, N’guessan NA, Assaré RK, Orsot MN, N’dri K, Yapi A. 2017. Epidemiology of schistosomiasis in Ahoué, southern Côte d’Ivoire. International Journal of Innovation and Applied Studies, 21(3), 378–387. [Google Scholar]
  54. Nyangiri OA, Edwige SA, Koffi M, Mewamba E, Simo G, Namulondo J, Mulindwa J, Nassuuna J, Elliott A, Karume K, Mumba D, Corstjens PLAM, Casacuberta-Partal M, van Dam GJ, Bucheton B, Noyes H, Matovu E, TrypanoGEN+ Research Group of the H3Africa Consortium. 2021. Candidate gene family-based and case-control studies of susceptibility to high Schistosoma mansoni worm burden in African children: a protocol. AAS Open Research, 4, 36. [CrossRef] [PubMed] [Google Scholar]
  55. Okoyo C, Simiyu E, Njenga SM, Mwandawiro C. 2018. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study. BMC Public Health, 18(1), 478. [CrossRef] [PubMed] [Google Scholar]
  56. Onyekwere AM, Rey O, Nwanchor MC, Alo M, Angora EK, Allienne JF, Boissier J. 2022. Prevalence and risk factors associated with urogenital schistosomiasis among primary school pupils in Nigeria. Parasite Epidemiology and Control, 18, e00255. [CrossRef] [PubMed] [Google Scholar]
  57. Ouattara M, Diakité NR, Yao PK, Saric J, Coulibaly JT, Assaré RK, Bassa FK, Koné N, Guindo-Coulibaly N, Hattendorf J, Utzinger J, N’Goran EK. 2021. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d’Ivoire: results of a 5-year cluster randomized trial. PLoS Neglected Tropical Diseases, 15(1), e0008845. [CrossRef] [PubMed] [Google Scholar]
  58. Pennington L, Hsieh M. 2014. The immunobiology of urogenital schistosomiasis in Immune response to parasitic infections, in Bentham science, vol. 2, Jirillo E, Magrone T, Miragliota G, Editors. p. 93–124. [Google Scholar]
  59. Pinot de Moira A, Fulford AJ, Kabatereine NB, Ouma JH, Booth M, Dunne DW. 2010. Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE. PLoS Neglected Tropical Diseases, 4(9), e820. [CrossRef] [PubMed] [Google Scholar]
  60. R Core Team. 2024. _R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing, Vienna, Austria. <https://www.R-project.org/>. [Google Scholar]
  61. Sassa M, Chadeka EA, Cheruiyot NB, Tanaka M, Moriyasu T, Kaneko S, Njenga SM, Cox SE, Hamano S. 2020. Prevalence and risk factors of Schistosoma mansoni infection among children under two years of age in Mbita, Western Kenya. PLoS Neglected Tropical Diseases, 14(8), e0008473. [CrossRef] [PubMed] [Google Scholar]
  62. Sokouri EA, Ahouty Ahouty B, N’Djetchi M, Abé IA, Yao BGFD, Konan TK, MacLeod A, Noyes H, Nyangiri O, Matovu E, Koffi M, TrypanoGEN+ Research Group of the H3Africa Consortium. 2024. Impact of environmental factors on Biomphalaria pfeifferi vector capacity leading to human infection by Schistosoma mansoni in two regions of western Côte d’Ivoire. Parasites & Vectors, 17(1), 179. [CrossRef] [PubMed] [Google Scholar]
  63. Vale N, Gouveia MJ, Rinaldi G, Brindley PJ, Gärtner F, Correia da Costa JM. 2017. Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance. Antimicrobial Agents and Chemotherapy, 61(5), e02582-16. [CrossRef] [PubMed] [Google Scholar]
  64. World Health Organization. 2011. Increasing access to diagnostics through technology transfer and local production. World Health Organization: Geneva. [Google Scholar]
  65. World Health Organization. 2020. Current estimated total number of individuals with morbidity and mortality due to Schistosomiasis haematobium and S. mansoni infection in Sub-saharan Africa. https://www.who.int/teams/control-of-neglected-tropical-diseases/schistosomiasis/epidemiology. [Google Scholar]
  66. World Health Organization. 2019. Bench aids for the diagnosis of intestinal parasites, 2nd edn. 32 p. https://www.who.int/publications-detail-redirect/9789241515344. [Google Scholar]
  67. World Health Organization. 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. World Health Organization: Geneva. https://apps.who.in/iris/handle/10665/42588. [Google Scholar]
  68. Worrell CM, Bartoces M, Karanja DM, Ochola EA, Matete DO, Mwinzi PN, Montgomery SP, Secor WE. 2015. Cost analysis of tests for the detection of Schistosoma mansoni infection in children in western Kenya. American Journal of Tropical Medicine and Hygiene, 92(6), 1233–1239. [CrossRef] [PubMed] [Google Scholar]
  69. Zhou YB, Liang S, Chen Y, Jiang QW. 2016. The Three Gorges Dam: does it accelerate or delay the progress towards eliminating transmission of schistosomiasis in China? Infectious Diseases of Poverty, 5(1), 63. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.